Opioid Dependence
📧 Sign up to get email alerts when something new happens for Opioid Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Re-Treatment Study of Probuphine in Opioid Addiction [Phase 3]
Phase 3 clinical trial update for re-treatment with Probuphine in opioid dependency has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence [Phase 3]
Phase 3 clinical trial update on Probuphine for opioid dependence evaluating safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence [Phase 3]
A Phase 3 extension study update for Probuphine assessing safety and efficacy in opioid dependence.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence [Phase 3]
Phase 3 trial comparing probuphine bioavailability and safety to sublingual buprenorphine in opioid dependence was terminated.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Study of Probuphine in Patients With Opioid Dependence [Phase 3]
Phase 3 study of Probuphine in patients with opioid dependence was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants [Phase 3]
Phase 3 trial evaluating transitioning adults with opioid dependence from daily sublingual buprenorphine to Probuphine subdermal implants; c…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8 [Phase 2]
Phase 2 clinical trial updating pharmacotherapy dosing regimens for individuals with cocaine abuse and opiate dependence; study terminated w…
-
FDA approval · 2018-10-31FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett Company's generic buprenorphine and naloxone product, enabling marketing of a generic fo…
-
FDA approval · 2018-10-31FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for a generic buprenorphine/naloxone product (Dr. Reddy's Laboratories) under ANDA 205299. The appro…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway [Phase 3]
Phase 3 trial comparing naltrexone to buprenorphine-naloxone for opioid dependence completed in Norway.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence [Phase 2]
A Phase 2 clinical trial updating on thienorphine hydrochloride tablets for relapse prevention in opioid dependence.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients [Phase 2]
Phase 2 trial update on gabapentin for benzodiazepine abuse in methadone-maintained patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence
Yale University's naturalistic study of adolescents and young adults in treatment for opioid dependence has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse [Phase 2]
Phase 2 clinical trial update on predictors of relapse for prescription opioid abuse among pain patients.
-
FDA approval · 2018-06-14FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's original Abbreviated New Drug Application for buprenorphine and naloxone tablets, a generic treatment for opioid depend…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Improved Strategies for Outpatient Opioid Detoxification [Phase 1]
Phase 1 clinical trial evaluating improved outpatient detoxification strategies for opioid dependence has completed. The document notes the …
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Pilot Test of a Community-based Buprenorphine Treatment Intervention [NA]
This Clinical Trial Update reports on the completion of a pilot community-based buprenorphine treatment intervention for opioid dependence w…
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine [Phase 3]
Phase 3 trial assessing tolerability of depot injections of buprenorphine for opioid use disorder has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence [Phase 2]
Phase 2 trial evaluating the separate and combined effects of Vivitrol (naltrexone extended-release) and opiate abstinence reinforcement in …
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 [NA]
This completed clinical trial from Johns Hopkins University tested employment-based reinforcement to promote drug abstinence. Participants h…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction [Phase 1]
A Phase 1 clinical trial update evaluating the exposures of lofexidine and its major metabolites in subjects seeking buprenorphine dose redu…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients [Phase 1]
Phase 1 trial assessing the pharmacodynamic interaction between lofexidine and methadone in methadone-maintained patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence [Phase 2]
Phase 2 clinical trial investigating glutamatergic modulation to aid initiation of naltrexone in opioid dependence has completed with posted…
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Nalrexone Facilitated Discontinuation of Buprenorphine [Phase 1, Phase 2]
A Phase 1/2 trial evaluating nalrexone-facilitated discontinuation of buprenorphine in individuals with stable opioid dependence has complet…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations [Phase 1, Phase 2]
Phase 1/2 trial evaluating naltrexone for opioid dependence in HIV+ criminal justice populations has completed with results posted.